D-0837-2020 Class II Terminated
FDA drug recall D-0837-2020 was initiated by Teva Pharmaceuticals USA on Jan 27, 2020 and is designated Class II. Reason for recall: CGMP deviations: Product bottle may be absent of desiccant. The recall status is terminated (terminated Nov 3, 2020). Affected quantity: 17,436 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 19, 2020
- Initiation Date
- Jan 27, 2020
- Termination Date
- Nov 3, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,436 bottles
Product description
Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01
Reason for recall
CGMP deviations: Product bottle may be absent of desiccant.
Distribution pattern
USA Nationwide
Code information
Lot # 1332799A, Exp 11/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0837-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026